BNB Plus (BNBX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Mar, 2026Executive summary
A Special Meeting will be held virtually on April 28, 2026, to vote on a reverse stock split and potential adjournment to solicit more votes if needed.
The reverse stock split proposal allows the Board to select a ratio between one-for-five and one-for-thirty within 12 months, aiming to increase the share price and maintain Nasdaq listing.
The Board is actively evaluating strategic alternatives, including mergers or acquisitions, with the reverse split seen as critical to these efforts.
The Board unanimously recommends voting in favor of both proposals.
Voting matters and shareholder proposals
Stockholders will vote on granting the Board authority for a reverse stock split and on the adjournment proposal to allow more time for vote solicitation if necessary.
Both proposals require a majority of shares present or represented by proxy to pass; abstentions count as votes against.
No dissenter's or appraisal rights are provided for either proposal.
Procedures for submitting future shareholder proposals and director nominations are outlined, with specific deadlines and requirements.
Board of directors and corporate governance
The Board retains discretion to implement or abandon the reverse split at any time within a year after approval.
The Board will consider market conditions, trading prices, and Nasdaq requirements in determining the split ratio.
No officer or director has a substantial interest in the reverse split not shared by all shareholders.
Latest events from BNB Plus
- Stockholders will vote on a reverse stock split to maintain Nasdaq listing and support strategic options.BNBX
Proxy Filing12 Mar 2026 - Net loss surged on lower revenue and one-time digital asset strategy expenses.BNBX
Q1 202612 Feb 2026 - BNBX targets 9%-12% annualized yield on BNB, offering direct exposure to Binance’s ecosystem.BNBX
Fintech & DATS Investor Conference4 Feb 2026 - BNB Plus targets 8%-12% annualized yield via BNB strategies and transparent treasury management.BNBX
Digital Asset Treasury Virtual Investor Conference3 Feb 2026 - Revenue fell sharply, but net income turned positive on a warrant gain; growth expected in FY25.BNBX
Q3 20242 Feb 2026 - GMP-ready linear DNA and RNA platforms enable rapid, high-quality genetic medicine production.BNBX
Maxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026 - Shifted to a BNB treasury model, raised $26.8M, cut costs 70%, and posted a $15.2M net loss.BNBX
Q4 202529 Dec 2025 - Revenue up 34%, exited DNA Tagging, GMP DNA site launched, but net loss widened on warrant charges.BNBX
Q1 202524 Dec 2025 - Raising capital to fund a BNB-focused treasury strategy amid high crypto and regulatory risks.BNBX
Registration Filing22 Dec 2025